Periorbital oedema secondary to emactuzumab treated with topical 2.5% phenylephrine

Emily Li; Alberto Distefano; Mahsa Sohrab

doi:10.1111/ceo.13498

Periorbital oedema secondary to emactuzumab treated with topical 2.5% phenylephrine

Emily Li, Alberto Distefano, Mahsa Sohrab

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	800-801
Number of pages	2
Journal	Clinical and Experimental Ophthalmology
Volume	47
Issue number	6
DOIs	https://doi.org/10.1111/ceo.13498
State	Published - 2019
Externally published	Yes

ASJC Scopus subject areas

Ophthalmology

Access to Document

10.1111/ceo.13498

Cite this

@article{8a35ec0c68e94231bac00a2ed318a064,

title = "Periorbital oedema secondary to emactuzumab treated with topical 2.5% phenylephrine",

author = "Emily Li and Alberto Distefano and Mahsa Sohrab",

year = "2019",

doi = "10.1111/ceo.13498",

language = "English (US)",

volume = "47",

pages = "800--801",

journal = "Clinical and Experimental Ophthalmology",

issn = "1442-6404",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "6",

}

TY - JOUR

T1 - Periorbital oedema secondary to emactuzumab treated with topical 2.5% phenylephrine

AU - Li, Emily

AU - Distefano, Alberto

AU - Sohrab, Mahsa

PY - 2019

Y1 - 2019

UR - http://www.scopus.com/inward/record.url?scp=85063662978&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063662978&partnerID=8YFLogxK

U2 - 10.1111/ceo.13498

DO - 10.1111/ceo.13498

M3 - Letter

C2 - 30859687

AN - SCOPUS:85063662978

SN - 1442-6404

VL - 47

SP - 800

EP - 801

JO - Clinical and Experimental Ophthalmology

JF - Clinical and Experimental Ophthalmology

IS - 6

ER -

Periorbital oedema secondary to emactuzumab treated with topical 2.5% phenylephrine

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this